Next Generation Sequencing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service (Human Genome Sequencing Services, Single Cell Sequencing Services, Microbial Genome-based Sequencing Services, Gene Regulation Services, Others), By Workflow (Pre-Sequencing, Sequencing, Data Analysis), By End User (Hospitals & Clinics, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Others), By Region and Competition, 2020-2030F

Market Overview

Global Next Generation Sequencing Services Market was valued at USD 5.97 billion in 2024 and is expected to reach USD 20.59 billion by 2030 with a CAGR of 22.92% during the forecast period. This growth is accounted for in advancements in genomic technologies, increasing demand for precision medicine, growing application of next generation sequencing in clinical research, and increasing prevalence of genetic disorders. Advancements in genomic technologies have led to the development of more advanced and efficient sequencing platforms, which have reduced the cost and time required for sequencing. This has made NGS more accessible to researchers and has driven the growth of the NGS Services Market.

The demand for precision medicine has increased significantly in recent years, as researchers and healthcare providers seek to develop personalized treatments for patients based on their unique genetic makeup. NGS services are essential for identifying genetic variations that may be relevant to disease diagnosis, prognosis, and treatment. NGS is increasingly being used in clinical research, including clinical trials and diagnostic testing. This has led to a growing demand for NGS services in the clinical research industry.

Moreover, the increasing prevalence of genetic disorders has driven the growth of the NGS Services Market. NGS can be used to diagnose genetic disorders and identify potential treatments, making it an essential tool for genetic testing and diagnosis. In the past few years, several new NGS services have been launched in the market. For example, in 2020, Illumina launched the NovaSeq 6000 system, which is designed to offer high-throughput sequencing with low per-sample costs. The system uses innovative flow cells and sequencing reagents to deliver high accuracy and cost-effectiveness, making it an attractive option for large-scale sequencing projects.

Key Market Drivers

Rising Demand for Personalized Medicine

The increasing demand for personalized medicine is a significant driver propelling the growth of the NGS services market. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, often based on genetic information. NGS technologies enable comprehensive analysis of an individual's genome, facilitating the identification of genetic mutations and variations that can influence disease susceptibility and treatment response.

Government initiatives worldwide are supporting the integration of personalized medicine into healthcare systems. For instance, the U.S. National Institutes of Health (NIH) has launched the All of Us Research Program, aiming to gather genetic data from diverse populations to advance personalized healthcare. Similarly, the European Union's Horizon 2020 program has allocated substantial funding for research in genomics and personalized medicine.

The growing prevalence of chronic diseases, such as cancer and cardiovascular disorders, further underscores the need for personalized treatment approaches. NGS services play a crucial role in identifying genetic markers associated with these diseases, enabling early diagnosis and the development of targeted therapies. As healthcare providers and researchers increasingly adopt personalized medicine, the demand for NGS services is expected to continue its upward trajectory.

Expansion of Applications in Agriculture and Environmental Research

Beyond healthcare, NGS services are finding expanding applications in agriculture and environmental research. In agriculture, NGS is utilized for crop and livestock improvement, disease resistance studies, and understanding plant-microbe interactions. For example, sequencing the genomes of crops like rice and wheat has led to the development of high-yield and disease-resistant varieties, contributing to food security.

Environmental research benefits from NGS through metagenomic studies, which analyze genetic material recovered directly from environmental samples. This approach aids in monitoring biodiversity, detecting pathogens in water sources, and assessing the impact of pollutants on ecosystems. Government agencies and international organizations are increasingly funding such initiatives to address global challenges like climate change and sustainable agriculture.

The versatility of NGS technologies in addressing diverse research questions across multiple disciplines is driving their adoption. As the cost of sequencing continues to decline and bioinformatics tools become more accessible, the utilization of NGS services in agriculture and environmental sciences is poised for significant growth.

Download Free Sample Report

Key Market Challenges

High Costs and Infrastructure Requirements

Despite the declining cost of sequencing per genome, the overall expenses associated with NGS remain a significant barrier to widespread adoption. Establishing and maintaining NGS facilities requires substantial investments in equipment, computational infrastructure, and skilled personnel. These costs can be prohibitive, especially for institutions in low- and middle-income countries.

The financial burden extends beyond initial setup to include ongoing expenses for reagents, maintenance, and data storage. Additionally, the complexity of NGS workflows necessitates continuous training and expertise, further increasing operational costs. These financial and logistical challenges limit the accessibility of NGS services, hindering their integration into routine clinical practice and research in resource-constrained settings.

To address these challenges, governments and international organizations are implementing funding programs and collaborative initiatives aimed at building genomic infrastructure and capacity. For instance, the African Union has launched the Africa Pathogen Genomics Initiative to enhance genomic surveillance capabilities across the continent. Such efforts are crucial in democratizing access to NGS technologies and ensuring their benefits are globally distributed.

Regulatory and Ethical Considerations

The implementation of NGS technologies raises regulatory and ethical issues, particularly concerning data privacy, consent, and the potential for genetic discrimination. Different countries have varying regulations governing genomic data, creating complexities for global service providers.

Ensuring compliance with data protection laws, such as the General Data Protection Regulation (GDPR) in the European Union, adds layers of responsibility for companies handling genomic information. Ethical concerns regarding the use of genetic data, especially in areas like insurance and employment, necessitate stringent oversight. Addressing these regulatory and ethical challenges is crucial for maintaining public trust and facilitating the responsible growth of the NGS services market.

Key Market Trends

Integration of Artificial Intelligence in NGS Data Analysis

The integration of artificial intelligence (AI) and machine learning (ML) into NGS data analysis is an emerging trend transforming the genomics landscape. NGS generates vast amounts of complex data that require sophisticated analytical tools for interpretation. AI and ML algorithms can efficiently process and analyze these datasets, identifying patterns and correlations that might be challenging to detect using traditional methods.

In clinical settings, AI-driven analysis enhances the accuracy of genetic diagnostics, enabling the identification of disease-causing mutations and the prediction of treatment responses. For instance, AI algorithms can assist in distinguishing between benign and pathogenic variants, streamlining the diagnostic process. In research, AI facilitates the discovery of novel biomarkers and therapeutic targets by uncovering hidden relationships within genomic data.

Governments and research institutions are investing in AI and genomics integration. The U.S. NIH has initiated programs to develop AI tools for biomedical research, recognizing the potential of AI to accelerate discoveries in genomics. As AI technologies continue to evolve, their synergy with NGS is expected to enhance the efficiency and effectiveness of genomic analyses, driving advancements in precision medicine and beyond.

Emergence of Portable and Point-of-Care NGS Devices

The development of portable and point-of-care NGS devices represents a significant trend aimed at decentralizing genomic testing. Traditional NGS platforms are often large, expensive, and confined to specialized laboratories, limiting their accessibility. In contrast, portable NGS devices enable on-site genomic analysis, which is particularly beneficial in remote or resource-limited settings.

These compact devices facilitate rapid diagnostics for infectious diseases, allowing for timely treatment decisions during outbreaks. For example, portable sequencers have been deployed in field settings to monitor viral pathogens like Ebola and Zika. In agriculture, they assist in the real-time detection of plant pathogens, aiding in crop protection. The portability and ease of use of these devices are expanding the reach of genomic technologies beyond traditional laboratories.

Government agencies are supporting the development and deployment of portable NGS technologies. Initiatives by organizations like the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) emphasize the importance of rapid diagnostics in managing public health emergencies. As technological advancements continue to miniaturize sequencing platforms, the adoption of portable NGS devices is expected to increase, enhancing global health surveillance and response capabilities.

Segmental Insights

Service Insights

Based on Service, the Human Genome Sequencing Services category held the largest share of the global Next Generation Sequencing (NGS) services market. This dominance can be attributed to the growing global emphasis on personalized medicine, disease risk assessment, and targeted therapeutic interventions, all of which rely heavily on comprehensive genome data. Human genome sequencing enables the identification of genetic predispositions to a wide array of diseases, including cancer, cardiovascular conditions, and rare inherited disorders.

Healthcare systems, research institutions, and biotechnology companies are increasingly leveraging human genome sequencing services to advance precision medicine and uncover genetic variations responsible for disease mechanisms. Moreover, various national genomics initiatives supported by governments such as the U.S.-based “All of Us” program and the UK’s 100,000 Genomes Project have further accelerated demand for human genome sequencing services.

Additionally, advancements in sequencing technologies have significantly lowered the cost and improved the turnaround time for whole-genome and whole-exome sequencing, making these services more accessible to a broader range of institutions.

Download Free Sample Report

Regional Insights

Based on the region, North America held the largest market share in the global Next Generation Sequencing (NGS) services market. This dominance is largely attributed to the region’s well-established genomic infrastructure, high adoption of advanced sequencing technologies, and substantial investment in precision medicine and personalized healthcare. The United States has led numerous large-scale genome projects and initiatives that have significantly propelled the use of NGS across academic, clinical, and pharmaceutical sectors. The presence of major biotechnology and genomics companies, coupled with strong collaborations between industry and academic institutions, has further reinforced North America's leadership in this space. Government support plays a key role as well—initiatives such as the All of Us Research Program by the National Institutes of Health (NIH) and various funding streams from the National Human Genome Research Institute (NHGRI) have created an ecosystem conducive to widespread NGS adoption.

Recent Developments

• In June 2024, Illumina, in association with Nashville Biosciences, announced the incorporation of Bristol Myers Squibb, Novo Nordisk and GSK in the Alliance for Genomic Discovery.
• In May 2024, Azenta announced the opening of its new Genomics laboratory in Oxford (United Kingdom) with an aim of expanding its GENEWIZ Multiomics & Synthesis Solutions in UK market. This new Genomics laboratory is aimed to provide NGS service using their advanced next generation sequencing platforms and a team of UK-based scientists from Oxford to the researchers.
• In October 2023, Revvity Omics, a NGS service provider adopted Element Biosciences’ AVITI genome sequencing platform to upgrade their technology capabilities.

Key Market Players

• Quest Diagnostics Inc.
• Applied Biological Materials, Inc.
• Novogene Co, Ltd.
• Azenta Life Sciences (GENEWIZ)
• NanoString Technologies, Inc.
• Illumina, Inc.
• PacBio, Inc.
• Gene by Gene Ltd
• Lucigen Corporation
• ARUP Laboratories

Report Scope:

In this report, the Global Next Generation Sequencing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Next Generation Sequencing Services Market, By Service:

o   Human Genome Sequencing Services

o   Single Cell Sequencing Services

o   Microbial Genome-based Sequencing Services

o   Gene Regulation Services

o   Others

• Next Generation Sequencing Services Market, By Workflow:

o   Pre-Sequencing

o   Sequencing

o   Data Analysis

• Next Generation Sequencing Services Market, By End User:

o   Hospitals & Clinics

o   Academic & Research Institutions

o   Pharmaceutical & Biotechnology Companies

o   Others

• Next Generation Sequencing Services Market, By Region:

o   North America

§  United States

§  Mexico

§  Canada

o   Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Japan

§  Australia

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East and Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Next Generation Sequencing Services Market.

Available Customizations:

Global Next Generation Sequencing Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Next Generation Sequencing Services Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]